Why the study?
The study evaluated self-monitoring of blood pressure and its variability to assess the influence on chronic kidney disease development.
Does blood pressure monitoring and targeted antihypertensive therapy improve blood pressure control and slow CKD progression in patients with various stages of CKD?
Does blood pressure monitoring and targeted antihypertensive therapy improve blood pressure control and slow CKD progression in patients with various stages of CKD?
Blood pressure variability and hypertension severity increase with advancing CKD stages, highlighting the need for strict BP monitoring and control to prevent CKD progression.
All patients conducted an explanation about monitoring the level of blood pressure in the form of self-control to assess its influence on the development of CKD, and also determined intrauditive and long-term variability (LTV).Due to the study, the presence of arterial hypertension is recorded as a risk factor for the progression of chronic kidney disease in the absence of clinical manifestations, the data indicate the need to study arterial hypertension as a risk factor for the development and progression of CKD during the initial examination of patients.In the early diagnosis of risk factors, normalization of the level of HTN, and the achievement of target blood pressure numbers is more effective.
No takes yet. Share an insight, caveat, or question.
KM et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: